AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 145 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.31 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $38,272,000 | -10.6% | 917,140 | +13.2% | 0.01% | -22.2% |
| Q3 2016 | $42,797,000 | +33.6% | 810,238 | +6.0% | 0.01% | +28.6% |
| Q2 2016 | $32,032,000 | +8.0% | 764,585 | +4.7% | 0.01% | 0.0% |
| Q1 2016 | $29,646,000 | -33.2% | 730,197 | +6.8% | 0.01% | -30.0% |
| Q4 2015 | $44,399,000 | -18.0% | 683,910 | -10.8% | 0.01% | -28.6% |
| Q3 2015 | $54,127,000 | -29.0% | 766,783 | +11.8% | 0.01% | -22.2% |
| Q2 2015 | $76,214,000 | -3.9% | 685,746 | -18.5% | 0.02% | -5.3% |
| Q1 2015 | $79,327,000 | -9.8% | 841,219 | +7.1% | 0.02% | -13.6% |
| Q4 2014 | $87,976,000 | +100.7% | 785,222 | +9.9% | 0.02% | +83.3% |
| Q3 2014 | $43,842,000 | +36.0% | 714,618 | +1.6% | 0.01% | +33.3% |
| Q2 2014 | $32,241,000 | +49.7% | 703,650 | +27.9% | 0.01% | +50.0% |
| Q1 2014 | $21,537,000 | +70.1% | 550,126 | +4.1% | 0.01% | +50.0% |
| Q4 2013 | $12,659,000 | +157.8% | 528,576 | +201.0% | 0.00% | +100.0% |
| Q3 2013 | $4,910,000 | – | 175,610 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |